Health professionals' views on the barriers and enablers to evidence-based practice for acute stroke care: A systematic review

Implementation Science

Volumn 12, Issue 1, 2017, Pages

  Baatiema, Leonard ^a,b   Otim, Michael E ^c   Mnatzaganian, George ^d   de Graft Aikins, Ama ^a   Coombes, Judith ^e   Somerset, Shawn ^b  

^a UNIVERSITY OF GHANA   (Ghana)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^c UNIVERSITY OF SHARJAH   (United Arab Emirates)

^d LA TROBE UNIVERSITY   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acute stroke; Barriers; Enablers; Evidence based practice; Services; Therapies

Indexed keywords

ADULT; CEREBROVASCULAR ACCIDENT; CLINICAL COMPETENCE; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE; PSYCHOLOGY; QUALITATIVE RESEARCH; STANDARDS;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; EVIDENCE-BASED PRACTICE; FEMALE; GUIDELINE ADHERENCE; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; QUALITATIVE RESEARCH; STROKE;

EID: 85020193994     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-017-0599-3     Document Type: Review

References (80)

1. Cochrane A. Effectiveness and efficiency: Random reflections on health services. London: Nuffield Provincial Hospitals Trust; 1972.
2. Grol R, Wensing M, Eccles M, Davis D. Improving patient care: the implementation of change in health care: John Wiley & Sons; 2013.
3. Straus S, Tetroe J, Graham ID. Knowledge translation in health care: moving from evidence to practice: John Wiley & Sons; 2013.
4. Grimshaw J, Eccles M, Thomas R, MacLennan G, Ramsay C, Fraser C, et al. Toward Evidence-Based Quality Improvement. J Gen Intern Med. 2006;21(S2):S14-20.
5. World Health Organisation. Research for Universal Health Coverage. Geneva: WHO; 2013.
6. Dopson S, Locock L, Gabbay J, Ferlie E, Fitzgerald L. Evidence-based medicine and the implementation gap. Health. 2003;7(3):311-30.
7. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003;362(9391):1225-30.
8. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510-20.
9. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-AC, et al. Why don't physicians follow clinical practice guidelines?: A framework for improvement. JAMA. 1999;282(15):1458-65.
10. Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of research findings. Implement Sci. 2012;7(1):50.
11. Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, et al. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2010;3(3).
12. Cochrane LJ, Olson CA, Murray S, Dupuis M, Tooman T, Hayes S. Gaps between knowing and doing: understanding and assessing the barriers to optimal health care. J Contin Educ Health Prof. 2007;27(2):94-102.
13. SURE Collaboration. SURE Guides for Preparing and Using Evidence-Based Policy Briefs: 5 Identifying and addressing barriers to implementing policy options. 2011.
14. Harvey G, Kitson A. Translating evidence into healthcare policy and practice: Single versus multi-faceted implementation strategies-is there a simple answer to a complex question? Int J Health Policy Manag. 2015;4(3):123.
15. Norrving B. Oxford Textbook of Stroke and Cerebrovascular Disease: Oxford University Press; 2014.
16. World Health Organization. Neurological disorders: public health challenges: World Health Organization; 2006.
17. Wright L, Hill KM, Bernhardt J, Lindley R, Ada L, Bajorek BV, et al. Stroke management: updated recommendations for treatment along the care continuum. Intern Med J. 2012;42(5):562-9.
18. Trialists'Collaboration SU. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013(4).
19. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 1993;342(8868):395-8.
20. Wardlaw JM MV, Berge E, del Zoppo GJ,. Thrombolysis for acute ischaemic stroke. Cochrane Database of Syst Rev 2014. 2014;Issue 7.
21. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-29.
22. NINDS. The National Institute of Neurological Disorders and Stroke Study Group. N Engl J Med. 1995;333:1581-7.
23. Sandercock P, Counsell C, Tseng M, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke (Review). Cochrane Database Syst Rev. 2014(3).
24. Collaboration AT. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308(6921):81-106.
25. Group ISTC. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569-81.
26. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215-22.
27. Cruz-Flores S, Berge E, Whittle IR. Surgical decompression for cerebral oedema in acute ischaemic stroke. The Cochrane Library. 2012.
28. National Institute for Health and Clinical Excellence. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA). London: Nation Collaborating Centre for Chronic Conditions; 2008. Report No.: 1860163394.
29. National Stroke Foundation. Clinical guidelines for stroke management 2010. Victoria: National Stroke Foundation; 2010.
30. Casaubon LK, Boulanger JM, Blacquiere D, Boucher S, Brown K, Goddard T, et al. Canadian stroke best practice recommendations: hyperacute stroke care guidelines, update 2015. Int J Stroke. 2015;10(6):924-40.
31. Jauch EC, Saver JL, Adams HP, Bruno A, Demaerschalk BM, Khatri P, et al. Guidelines for the early management of patients with acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947.
32. Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9(7):840-55.
33. Intercollegiate Stroke Working Party. National clinical guideline for stroke. 4th ed. London: Royal College of Physicians; 2012.
34. Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2015;46(7):2032-60.
35. Berkowitz AL, Mittal MK, McLane HC, Shen GC, Muralidharan R, Lyons JL, et al. Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke. Int J Stroke. 2014;9(3):349-55.
36. Langhorne P, de Villiers L, Pandian JD. Applicability of stroke-unit care to low-income and middle-income countries. Lancet Neurol. 2012;11(4):341-8.
37. Norrving B, Kissela B. The global burden of stroke and need for a continuum of care. Neurology. 2013;80(3 Suppl 2):S5-12.
38. Baatiema L, Otim M, Mnatzaganian G, Aikins AD-G, Coombes J, Somerset S. Towards best practice in acute stroke care in Ghana: a survey of hospital services. BMC Health Serv Res. 2017;17(1):108.
39. Dale S, Levi C, Ward J, Grimshaw JM, Jammali-Blasi A, D'Este C, et al. Barriers and Enablers to Implementing Clinical Treatment Protocols for Fever, Hyperglycaemia, and Swallowing Dysfunction in the Quality in Acute Stroke Care (QASC) Project-A Mixed Methods Study. Worldviews Evid-Based Nurs. 2015;12(1):41-50.
40. Donnellan C, Sweetman S, Shelley E. Health professionals' adherence to stroke clinical guidelines: a review of the literature. Health Policy. 2013;111(3):245-63.
41. Kwan J, Hand P, Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing. 2004;33(2):116-21.
42. Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess (Winchester, England). 2001;6(26):1-112.
43. Eissa A, Krass I, Bajorek B. Barriers to the utilization of thrombolysis for acute ischaemic stroke. J Clin Pharm Ther. 2012;37(4):399-409.
44. Johnson M, Bakas T. A review of barriers to thrombolytic therapy: Implications for nursing care in the emergency department. J Neurosci Nurs. 2010;42(2):88-94.
45. Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess. 2002;6(26):1-112.
46. Baatiema L, De-Graft Aikins A, Sav A, Mnatzaganian G, Chan CKY. Somerset S. Barriers to evidence-based acute stroke care in Ghana: A qualitative study on the perspectives of stroke care professionals. BMJ Open. 2017;7(4):e015385. doi: 10.1136/bmjopen-2016-015385.
47. Glasziou P, Straus S, Brownlee S, Trevena L, Dans L, Guyatt G,. & Saini V. Evidence for underuse of effective medical services around the world. The Lancet. 2017. doi.org/10.1016/S0140-6736(16)30946-1
48. Craig LE, McInnes E, Taylor N, Grimley R, Cadilhac DA, Considine J, et al. Identifying the barriers and enablers for a triage, treatment, and transfer clinical intervention to manage acute stroke patients in the emergency department: a systematic review using the theoretical domains framework (TDF). Implement Sci. 2016;11(1):157.
49. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355-69.
50. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8(4):345-54.
51. Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016.
52. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-9.
53. Dopson S, Fitzgerald L. Knowledge to action?: evidence-based health care in context. Oxford: Oxford University Press; 2005.
54. Wensing M, Oxman A, Baker R, Godycki-Cwirko M, Flottorp S, Szecsenyi J, et al. Tailored implementation for chronic diseases (TICD): a project protocol. Implement Sci. 2011;6(1):103.
55. Flottorp SA, Oxman AD, Krause J, Musila NR, Wensing M, Godycki-Cwirko M, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci. 2013;8(1):35.
56. Joanna Briggs Institute. Systematic Review Resource Package. Adelaide: The Joanna Briggs Institute; 2015.
57. Centre for Evidence Based Management. Critical appraisal of a survey UK2014 [Available from: http://www.cebma.org/wp-content/uploads/Critical-Appraisal-Questions-for-a-Survey.pdf.
58. Dixon-Woods M, Bonas S, Booth A, Jones DR, Miller T, Sutton AJ, et al. How can systematic reviews incorporate qualitative research? A critical perspective. Qual Res. 2006;6(1):27-44.
59. Atkins S, Lewin S, Smith H, Engel M, Fretheim A, Volmink J. Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol. 2008;8(1):21.
60. Meurer WJ, Majersik JJ, Frederiksen SM, Kade AM, Sandretto AM, Scott PA. Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study. BMC Emerg Med. 2011;11(1):5.
61. Stecksén A, Lundman B, Eriksson M, Glader E-L, Asplund K. Implementing Thrombolytic Guidelines in Stroke Care Perceived Facilitators and Barriers. Qual Health Res. 2013:1049732313514137.
62. Purvis T, Moss K, Denisenko S, Bladin C, Cadilhac DA. Implementation of evidence-based stroke care: enablers, barriers, and the role of facilitators. J Multidiscip Healthc. 2014;7:389.
63. Chan Y-F, Kwiatkowski TG, Rella JG, Rennie WP, Kwon RK, Silverman RA. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective. J Emerg Med. 2005;29(4):405-8.
64. Grady A, Bryant J, Carey M, Paul C, Sanson-Fisher R. Enablers of the Implementation of Tissue Plasminogen Activator in Acute Stroke Care: A Cross-Sectional Survey. PLoS One. 2014;9(12):e114778.
65. Hargis M, Shah JN, Mazabob J, Rao CV, Suarez JI, Bershad EM. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers. Clin Neurol Neurosurg. 2015;135:79-84.
66. O'Rourke F, Chan DKY, Chan DL, Ding XM. Preferences, barriers and facilitators for establishing comprehensive stroke units: a multidisciplinary survey. Aust Health Rev. 2013;37(3):318-23.
67. Slot KB, Murray V, Boysen G, Berge E. Thrombolytic treatment for stroke in the Scandinavian countries. Acta Neurol Scand. 2009;120(4):270-6.
68. Van Der Weijden T, Hooi JD, Grol R, Limburg M. A multidisciplinary guideline for the acute phase of stroke: barriers perceived by Dutch neurologists. J Eval Clin Pract. 2004;10(2):241-6.
69. Williams JM, Jude MR, Levi CR. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: A survey of barriers and enablers. Aust J Rural Health. 2013;21(5):262-7.
70. Ehlers L, Jensen LG, Bech MA, Andersen G, Kjølby M. Organisational barriers to thrombolysis treatment of acute ischaemic stroke. Curr Med Res Opin. 2007;23(11):2833-9.
71. Donnellan C, Sweetman S, Shelley E. Implementing clinical guidelines in stroke: a qualitative study of perceived facilitators and barriers. Health Policy. 2013;111(3):234-44.
72. Saver JL. Time is brain-quantified. Stroke. 2006;37(1):263-6.
73. Dombrowski SU, Mackintosh JE, Sniehotta FF, Araujo-Soares V, Rodgers H, Thomson RG, et al. The impact of the UK 'Act FAST'stroke awareness campaign: content analysis of patients, witness and primary care clinicians' perceptions. BMC Public Health. 2013;13(1):915.
74. Mellon L, Hickey A, Doyle F, Dolan E, Williams D. Can a media campaign change health service use in a population with stroke symptoms? Examination of the first Irish stroke awareness campaign. Emerg Med J. 2014;31(7):536-40.
75. Donkor E, Owolabi M, Bampoh P, Aspelund T, Gudnason V. Community awareness of stroke in Accra, Ghana. BMC Public Health. 2014;14(1):196.
76. Mensah GA. Epidemiology of stroke and high blood pressure in Africa. Heart. 2008;94(6):697-705.
77. Brainin M, Teuschl Y, Kalra L. Acute treatment and long-term management of stroke in developing countries. Lancet Neurol. 2007;6(6):553-61.
78. Thrift AG, de los Rios F. Expanding antiplatelet use for patients with stroke The case for stroke of unknown type. Neurology. 2014;83(9):778-9.
79. Schuster MA, McGlynn EA, Brook RH. How good is the quality of health care in the United States? Milbank Q. 1998;76(4):517-63.
80. Lewin S, Glenton C, Munthe-Kaas H, Carlsen B, Colvin CJ, Gülmezoglu M, et al. Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Med. 2015;12(10):e1001895.